Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

PXA PEER ANALYSIS

Pexa Group Ltd — metric-by-metric comparison with peers and the industry median

PXAPexa Group Ltd

🇦🇺 Australia · AU · Technology · Software - Application

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Software - Application

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityFinancial Health
PXAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
PXA-33.3%LSPD-6.3%RDVT+34.8%XPER+1.2%MITK+87.8%UPBD-19.7%
Year-to-Date (YTD)
PXA-36.4%LSPD-9.3%RDVT+15.0%XPER+39.9%MITK+82.1%UPBD+15.7%
1-Year
Split-adjusted
PXA-33.3%360-15.5%NWL-32.4%TNE-24.1%WTC-70.2%XRO-59.1%
Year-to-Date (YTD)
PXA-36.4%360-18.1%NWL-11.1%TNE+9.3%WTC-51.8%XRO-36.6%

Key Metric Comparison

P/E

Lower is better
PXA—LSPD—RDVT66.88XPER—MITK56.29UPBD13.82Median 30.76

ROE

Higher is better
PXA-5.1%LSPD-9.2%RDVT14.4%XPER-11.1%MITK7.2%UPBD12.1%Median 11.5%

Net Margin

Higher is better
PXA-14.9%LSPD-11.8%RDVT15.0%XPER-10.2%MITK8.7%UPBD1.8%Median 8.1%

Revenue Growth

Higher is better
PXA—LSPD14.0%RDVT18.1%XPER-8.3%MITK6.9%UPBD7.7%Median 13.4%

P/E

Lower is better
PXA—36032.83NWL97.78TNE70.96WTC68.15XRO73.01Median 30.76

ROE

Higher is better
PXA-5.1%36031.0%NWL34.6%TNE33.5%WTC9.4%XRO4.7%Median 11.5%

Net Margin

Higher is better
PXA-14.9%36028.6%NWL16.0%TNE22.4%WTC15.2%XRO6.1%Median 8.1%

Revenue Growth

Higher is better
PXA—36033.6%NWL23.4%TNE14.5%WTC40.9%XRO36.1%Median 13.4%

All Metrics

Valuation
MetricPXALSPDRDVTXPERMITKUPBDInd. Median
P/E——66.88—56.2913.82●30.76
P/B1.340.99●9.022.303.891.634.28
EV/EBITDA12.7067.3837.9118.3918.862.67●16.48
P/S3.891.2010.022.094.920.25●3.45
Financial Health
MetricPXALSPDRDVTXPERMITKUPBDInd. Median
Current Ratio1.624.1611.22●2.362.612.961.45
Debt/Equity27.0%1.4%●2.6%16.6%21.9%241.4%32.2%
NetDebt/EBITDA1.65-28.21●-1.71-0.05-0.521.56-0.05
Profitability
MetricPXALSPDRDVTXPERMITKUPBDInd. Median
Net Margin-14.9%-11.8%15.0%●-10.2%8.7%1.8%8.1%
ROE-5.1%-9.2%14.4%●-11.1%7.2%12.1%11.5%
ROA-3.5%-8.3%13.3%●-7.4%4.2%2.7%4.7%
EBITDA Margin35.2%●1.3%25.3%11.3%25.4%22.0%16.0%
Growth + Dividend
MetricPXALSPDRDVTXPERMITKUPBDInd. Median
Rev. Growth—14.0%18.1%●-8.3%6.9%7.7%13.4%
NI Growth——62.9%●—24.3%-30.1%9.5%
Div. Yield—0.0%—3.0%—7.5%●1.0%
Payout—0.0%—-61.8%—106.3%17.6%
Valuation
MetricPXA360NWLTNEWTCXROInd. Median
P/E—32.83●97.7870.9668.1573.0130.76
P/B1.34●8.1537.1123.454.062.264.28
EV/EBITDA12.70●124.4471.2635.8319.2314.1816.48
P/S3.89●9.2415.6515.906.794.303.45
Financial Health
MetricPXA360NWLTNEWTCXROInd. Median
Current Ratio1.625.36●1.771.081.381.091.45
Debt/Equity27.0%55.2%15.4%11.5%●135.3%39.3%32.2%
NetDebt/EBITDA1.65-3.34●-2.12-0.714.270.22-0.05
Profitability
MetricPXA360NWLTNEWTCXROInd. Median
Net Margin-14.9%28.6%●16.0%22.4%15.2%6.1%8.1%
ROE-5.1%31.0%34.6%●33.5%9.4%4.7%11.5%
ROA-3.5%20.2%21.2%●18.2%4.7%2.6%4.7%
EBITDA Margin35.2%7.2%21.3%43.5%45.4%●30.8%16.0%
Growth + Dividend
MetricPXA360NWLTNEWTCXROInd. Median
Rev. Growth—33.6%23.4%14.5%40.9%●36.1%13.4%
NI Growth—1,476.4%●-44.2%6.4%-21.9%-23.8%9.5%
Div. Yield——1.9%●0.9%0.5%—1.0%
Payout——166.2%84.5%28.9%—17.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PXA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.